Greater Cannabis Company (GCAN) Return on Capital Employed Growth (5y) (2023 - 2026)
Greater Cannabis Company (GCAN) Return on Capital Employed Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,343.00 |
| Dec 31, 2025 | -8,915.00 |
| Sep 30, 2025 | -4,938.00 |
| Jun 30, 2025 | -2,820.00 |
| Mar 31, 2025 | -417.00 |
| Dec 31, 2024 | -1,606.00 |
| Sep 30, 2024 | -4,633.00 |
| Jun 30, 2024 | -8,336.00 |
| Mar 31, 2024 | -3,772.00 |
| Dec 31, 2023 | -602.00 |